Stay updated with breaking news from Colin weekes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ST LUCIA JUNIOR JAZZ & ARTS FESTIVAL 2024 ieyenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ieyenews.com Daily Mail and Mail on Sunday newspapers.
SUV up for grabs in Massy Stores' Christmas Jackpot Promotion inewsguyana.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inewsguyana.com Daily Mail and Mail on Sunday newspapers.
PanCAN’s Scientific & Medical Advisory Board (SMAB) welcomes new leadership and members, representing the foremost expertise in the field of pancreatic cancer from institutions across the US.
Nonprofit’s Scientific and Medical Advisory Board Represented by Foremost Leaders in Pancreatic Cancer Field LOS ANGELES, Calif. – (July 18, [...] READ MORE
/PRNewswire/ -- The Pancreatic Cancer Action Network (PanCAN), a leading nonprofit in the fight against pancreatic cancer, proudly announces the addition of...
Local financial services entity Sagicor was pleased to support the efforts of the John E Sabga Foundation for Pancreatic Cancer through a recent $25,000 donation. Robert Trestrail, president and CEO, Sagicor Life Inc, Southern Caribbean, said, “As the region’s leading health and life insurer, we are pleased to continue our support of cancer awareness and
Hold Off on Approving Anal Cancer Drug, Advisors Tell FDA medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
Hold Off on Approving Anal Cancer Drug, Advisors Tell FDA medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
email article An advisory committee recommended that the FDA revoke the accelerated approval for pembrolizumab (Keytruda) as a third-line option in gastric or gastroesophageal junction (GEJ) cancer. With a vote of 6-2, the Oncologic Drugs Advisory Committee (ODAC) on Thursday recommended against maintaining the PD-1 immune checkpoint inhibitor's indication for patients with metastatic or recurrent locally advanced gastric or GEJ cancers with tumors expressing PD-L1. Committee members overwhelmingly cited the new availability of a PD-1 inhibitor, in combination with chemotherapy, in the upfront setting, as well as the fact that patients who have already received chemotherapy alone as their initial therapy could still access pembrolizumab through expanded use programs.